LA
LVW Advisors Portfolio holdings
AUM
$893M
1-Year Return
14.96%
This Quarter Return
+7.51%
1 Year Return
+14.96%
3 Year Return
+54.51%
5 Year Return
+88.33%
10 Year Return
+157.12%
AUM
$893M
AUM Growth
+$63.5M
(+7.7%)
Cap. Flow
+$18.9M
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
48.8%
Holding
341
New
44
Increased
158
Reduced
110
Closed
15
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
$65.3M |
| 2 |
Capital Group Global Growth Equity ETF
CGGO
|
$5.69M |
| 3 |
Capital Group International Equity ETF
CGIE
|
$3.24M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
$2.3M |
| 5 |
Microsoft
MSFT
|
$1.88M |
Top Sells
| 1 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
$65.7M |
| 2 |
Vanguard Growth ETF
VUG
|
$7.62M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
$5.71M |
| 4 |
Vanguard Total Bond Market
BND
|
$4.72M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
$2.09M |
Sector Composition
| 1 | Technology | 11.02% |
| 2 | Financials | 6.76% |
| 3 | Healthcare | 3.68% |
| 4 | Industrials | 3.49% |
| 5 | Consumer Discretionary | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Regions Financial
RF
$24.4B
| $268K | 0.03% |
+11,398
| New | +$268K |
|
277
Accenture
ACN
$158B
| $268K | 0.03% |
896
-34
| -4% | -$10.2K |
|
278
AB InBev
BUD
$116B
| $262K | 0.03% |
3,816
-3,799
| -50% | -$261K |
|
279
Xylem
XYL
$34.5B
| $261K | 0.03% |
2,020
-468
| -19% | -$60.5K |
|
280
BP
BP
$88.4B
| $259K | 0.03% |
8,661
-2,751
| -24% | -$82.3K |
|
281
Hubbell
HUBB
$23.2B
| $259K | 0.03% |
+634
| New | +$259K |
|
282
Sysco
SYY
$39.5B
| $257K | 0.03% |
3,387
+275
| +9% | +$20.8K |
|
283
Fortinet
FTNT
$58.6B
| $256K | 0.03% |
2,417
-84
| -3% | -$8.88K |
|
284
Mondelez International
MDLZ
$78.8B
| $253K | 0.03% |
+3,755
| New | +$253K |
|
285
ReposiTrak
TRAK
$307M
| $251K | 0.03% |
12,775
| – | – |
|
286
Aflac
AFL
$58.1B
| $251K | 0.03% |
2,380
+431
| +22% | +$45.5K |
|
|
ONC
287
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.1B
| $247K | 0.03% |
1,022
-7
| -0.7% | -$1.69K |
|
288
iShares Silver Trust
SLV
$20B
| $247K | 0.03% |
+7,537
| New | +$247K |
|
289
Arcutis Biotherapeutics
ARQT
$1.94B
| $246K | 0.03% |
17,561
+3,095
| +21% | +$43.4K |
|
290
Lam Research
LRCX
$127B
| $245K | 0.03% |
+2,522
| New | +$245K |
|
291
Illinois Tool Works
ITW
$77.4B
| $243K | 0.03% |
983
-539
| -35% | -$133K |
|
292
Charles Schwab
SCHW
$177B
| $241K | 0.03% |
2,639
-31
| -1% | -$2.83K |
|
293
Tompkins Financial
TMP
$1.02B
| $237K | 0.03% |
3,781
| – | – |
|
294
Synopsys
SNPS
$111B
| $236K | 0.03% |
+461
| New | +$236K |
|
295
Best Buy
BBY
$16.3B
| $235K | 0.03% |
3,496
-1,207
| -26% | -$81K |
|
296
T-Mobile US
TMUS
$284B
| $232K | 0.03% |
972
+32
| +3% | +$7.62K |
|
297
PPL Corp
PPL
$27B
| $229K | 0.03% |
6,764
| – | – |
|
298
McCormick & Company Non-Voting
MKC
$18.8B
| $228K | 0.02% |
3,010
-309
| -9% | -$23.4K |
|
299
Natera
NTRA
$22.9B
| $225K | 0.02% |
1,333
-320
| -19% | -$54.1K |
|
300
CVS Health
CVS
$93.5B
| $219K | 0.02% |
3,173
-855
| -21% | -$59K |
|